Your search found 3 Results
British Journal of Family Planning. 1984 Jul; 10(37):37.This editorial takes a broad, international look at the worldwide implications of decisions taken in the United Kingdom (U.K.) and the US with regard to family planning. National authorities, like the U.K. Committee for Safety of Medicines (CSM) of the US Food and Drug Administration, address issues concerning the safety of pharmaceutical products in terms of risk/benefit ratios applicable in their countries. International repercussions of US and U.K. decision making must be considered, especially in the area of pharmaceutical products, where they have an important world leadership role. Much of the adverse publicity of the use of Depo-Provera has focused on the fact that it was not approved for longterm use in the U.K. and the US. It is not equally known that the CSM, IPPF and WHO recommeded approval, but were overruled by the licensing agencies. The controversy caused by the Lancet articles of Professors with family planning doctors. At present several family planning issues in the U.K., such as contraception for minors, have implications for other countries. A campaign is being undertaken to enforce 'Squeal' laws in the U.K. and the US requiring parental consent for their teenagers under 16 to use contraceptives. In some developing countries, urbanization heightens the problem of adolescent sexuality. Carefully designed adolescent programs, stressing the need for adequate counseling, are needed. Many issues of international interest go unnoticed in the U.K. International agencies, like the WHO and UNiCEF, have embarked on a global program to promote lactation both for its benficial effects on an infant's growth and development and for birth spacing effects. It may be of benefit to family planning professionals in the U.K. to pay attention to international activity in such issues.
In: Inter Governmental Coordinating Committee. Southeast Asia Regional Cooperation in Family and Population Planning. A Report on the IGCC Regional Expert Meeting between Family Planning Administrators and Commercial Marketing Executives held in Penang, Malaysia, 22-24 September 1974. Kuala Lumpur, Malaysia, IGCC Secretariat, 1975. 53-4.The IPPF Central Medicine Committee has concluded that non-medical distribution of oral contraceptives is appropriate, and that such methods of distribution can and should be devised. Accordingly, the Committee recommends Member Associations to 1) devise and introduce new schemes for distribution of oral contraceptives, along with other contraceptives; 2) persuade governments and the medical profession of the health benefits to mothers and children of non-medical distribution of oral contraceptives; 3) establish educational and informative programs which describe the use of oral contraceptives, relative contraindications, and possible side effects; and 4) reorganize clinic facilities to ensure easy access to trained personnel in the event that a woman is uncertain about the use of oral contraceptives, needs reassurance, or has a complicated medical condition. The Committee deems these measures appropriate because the limitation of oral contraceptives to doctors' prescription is geographically, economically, and culturally discriminatory and results in more deaths and sickness to women and children than would be the case if fertility were voluntairly controlled.
New York, Rockefeller Foundation. 1974 June; 98.31 participants, representing in the main specialists from international public and private agencies, together with regional representatives from the developing world, gathered in Bellagio, Italy, in May 1973, to discuss world population growth. A record of that conference, consisting of some of the position papers and a small portion of the attending dialogue, is presented. Topics include: 1) status report on population developments; 2) sociopolitical implications of family planning programs as an aspect of population policies and development planning in Africa; 3) population and family planning programs in Latin America--programs and prospects; 4) emerging issues in population policy and population program assistance; 5) an overview of agency activities; 6) social research and population policy; 7) university programs and population centers; 8) delivery systems for family planning; 9) contraceptive development; 10) demographic data collection and analysis; and 11) population education: school and nonschool.